article_metadata: Wen Dong Pengfei Lei Xin Liu Qin Li Xiangyang Cheng
article_metadata: 10.3389/fimmu.2021.686057
article_metadata: Front Immunol
article_metadata: 2021 Nov 4;12:686057.
article_metadata: eml4-alk pd-l1 complete remission lung cancer nivolumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34804000/
article_metadata: Adenocarcinoma of Lung / drug therapy Adenocarcinoma of Lung / genetics Lung Neoplasms / drug therapy Lung Neoplasms / genetics Nivolumab / therapeutic use
article_metadata: Adenocarcinoma of Lung / drug therapy Adenocarcinoma of Lung / genetics Lung Neoplasms / drug therapy Lung Neoplasms / genetics Nivolumab / therapeutic use Case Reports Adenocarcinoma of Lung / pathology Adult Anaplastic Lymphoma Kinase / genetics B7-H1 Antigen / genetics Cell Cycle Proteins / genetics Humans Lung Neoplasms / pathology Male Microtubule-Associated Proteins / genetics Mutation Nivolumab / pharmacology Protein Kinase Inhibitors / therapeutic use Proto-Oncogene Proteins B-raf / genetics Serine Endopeptidases / genetics Treatment Outcome Tumor Microenvironment B7-H1 Antigen Cell Cycle Proteins Microtubule-Associated Proteins Protein Kinase Inhibitors Nivolumab ALK protein, human Anaplastic Lymphoma Kinase BRAF protein, human Proto-Oncogene Proteins B-raf EML4 protein, human Serine Endopeptidases
article_metadata: PMC8600068
article_metadata: 34804000
article_metadata: Case Report: Complete Response to Nivolumab in a Patient With Programmed Cell Death 1 Ligand 1-Positive and Multiple Gene-Driven Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Resistant Lung Adenocarcinoma
article_metadata: 2021